DrugMAP 2.0: molecular atlas and pharma-information of all drugs
Nucleic Acids Research · 06.01.2025 · 53 (D1) · D1372-D1382
DOI: 10.1093/nar/gkae791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 13.09.2024. Verfasst von Fengcheng Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Children's Hospital, The Second Affiliated Hospital, Zhejiang University School of Medicine, National Clinical Re…. Hauptthemen laut MEDLINE: Drug Discovery. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Fundamental Research Funds for Central Universities.
Abstract (Originalsprache)
The escalating costs and high failure rates have decelerated the pace of drug development, which amplifies the research interests in developing combinatorial/repurposed drugs and understanding off-target adverse drug reaction (ADR). In other words, it is demanded to delineate the molecular atlas and pharma-information for the combinatorial/repurposed drugs and off-target interactions. However, such invaluable data were inadequately covered by existing databases. In this study, a major update was thus conducted to the DrugMAP, which accumulated (a) 20831 combinatorial drugs and their interacting atlas involving 1583 pharmacologically important molecules; (b) 842 repurposed drugs and their interacting atlas with 795 molecules; (c) 3260 off-targets relevant to the ADRs of 2731 drugs and (d) various types of pharmaceutical information, including diverse ADMET properties, versatile diseases, and various ADRs/off-targets. With the growing demands for discovering combinatorial/repurposed therapies and the rapidly emerging interest in AI-based drug discovery, DrugMAP was highly expected to act as an indispensable supplement to existing databases facilitating drug discovery, which was accessible at: https://idrblab.org/drugmap/.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Sciences, Children's Hospital, The Second Affiliated Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Zhejiang University, Hangzhou 310058,…
- State Key Lab of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou 310058, China.
- Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Alibaba-Zhejiang University Joint Research Center of Future Digital Healthcare, Hangzhou 330110, China.
- Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou 310058, China.
- School of Pharmacy, Hebei Medical University, Shijiazhuang 050017, China.
ORCID-Profile: Minjie Mou, Feng Zhu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- Fundamental Research Funds for Central Universities
- National Key R&D Program of China
- Double Top-Class University
- Key R&D Program of Zhejiang
- Westlake Laboratory
- Leading Talent of the ‘Ten Thousand Plan’ National High-Level Talents Special Support Plan of China
Zitieren
APA
Li, F., Mou, M., Li, X., Xu, W., Yin, J., Zhang, Y., & Zhu, F. (2025). DrugMAP 2.0: molecular atlas and pharma-information of all drugs. Nucleic Acids Research, 53(D1), D1372-D1382. https://doi.org/10.1093/nar/gkae791
Vancouver
Li F, Mou M, Li X, Xu W, Yin J, Zhang Y, et al. DrugMAP 2.0: molecular atlas and pharma-information of all drugs. Nucleic Acids Research. 2025;53(D1):D1372-D1382. doi:10.1093/nar/gkae791
BibTeX
@article{Li2025,
author = {Li, Fengcheng and Mou, Minjie and Li, Xiaoyi and Xu, Weize and Yin, Jiayi and Zhang, Yang and Zhu, Feng},
title = {DrugMAP 2.0: molecular atlas and pharma-information of all drugs},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {D1},
pages = {D1372--D1382},
doi = {10.1093/nar/gkae791}
}
EUVIMED